# Personalized Precision Diagnosis and Treatment of Pancreatic Cancer

> **NCT04373928** · NA · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **PROCEDURE:** Drug guided by Mini-PDX/PDX

## Key facts

- **NCT ID:** NCT04373928
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-10
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04373928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04373928, "Personalized Precision Diagnosis and Treatment of Pancreatic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04373928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*